<html><head></head><body><h1>Nystatin Vaginal Insert</h1><p class="drug-subtitle"><b>Dosage Form:</b> vaginal insert<br/></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li>Overview</li>
<li>Side Effects</li>
<li>Dosage</li>
<li>Professional</li>
<li>Interactions</li>
<li class="nav-more">
More&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewBox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/body&gt;&lt;/html&gt;
</li>
</ul><ul>
<li>Description</li>
<li>Clinical Pharmacology</li>
<li>Indications and Usage</li>
<li>Contraindications</li>
<li>Precautions</li>
<li>Patient Counseling Information</li>
<li>Adverse Reactions/Side Effects</li>
<li class="ddc-toggle-hidden">Dosage and Administration</li>
<li class="ddc-toggle-hidden">How Supplied/Storage and Handling</li>
</ul><h2>Nystatin Vaginal Insert Description</h2><p class="First">Nystatin is an antimycotic polyene antibiotic obtained from <span class="Italics">Streptomyces noursei</span>.</p><p>Nystatin Vaginal Inserts, USP are available as oval-shaped compressed inserts for intravaginal administration, each containing 100,000 units Nystatin, USP. Inactive ingredients include corn starch, ethylcellulose, anhydrous lactose, microcrystalline cellulose, polyethylene glycol and stearic acid.</p><h2>Nystatin Vaginal Insert - Clinical Pharmacology</h2><p class="First">Nystatin is both fungi-static and fungicidal <span class="Italics">in vitro</span> against a wide variety of yeasts and yeast-like fungi. Nystatin acts by binding to sterols in the cell membrane of sensitive fungi with a resultant change in membrane permeability allowing leakage of intracellular components. Nystatin exhibits no appreciable activity against bacteria, protozoa, trichomonads or viruses.</p><p>Nystatin is not absorbed from intact skin or mucous membranes.</p><h2>Indications and Usage for Nystatin Vaginal Insert</h2><p class="First">Nystatin Vaginal Inserts, USP are effective for the local treatment of vulvovaginal candidiasis (moniliasis). The diagnosis should be confirmed, prior to therapy, by KOH smears and/or cultures. Other pathogens commonly associated with vulvovaginitis (Trichomonas and <span class="Italics">Haemophilus vaginalis</span>) do not respond to nystatin and should be ruled out by appropriate laboratory methods.</p><h2>Contraindications</h2><p class="First">This preparation is contraindicated in patients with a history of hypersensitivity to any of its components.</p><h2>Precautions</h2><h3>General</h3><p class="First">Discontinue treatment if sensitization or irritation is reported during use.</p><h3>Information for Patients</h3><p class="First">The patient should be informed of symptoms of sensitization or irritation and told to report them promptly.</p><p>The patient should be warned against interruption or discontinuation of medication even during menstruation and even though symptomatic relief may occur within a few days.</p><p>The patient should be advised that adjunctive measures such as therapeutic douches are unnecessary and sometimes inadvisable, but cleansing douches may be used by nonpregnant women, if desired, for esthetic purposes.</p><h3>Laboratory Tests</h3><p class="First">If there is a lack of response to Nystatin Vaginal Inserts, USP, appropriate microbiological studies should be repeated to confirm the diagnosis and rule out other pathogens before instituting another course of antimycotic therapy (see INDICATIONS AND USAGE).</p><h3>Carcinogenesis, Mutagenesis, Impairment of Fertility</h3><p class="First">Long-term studies in animals have not been performed to evaluate carcinogenic potential, mutagenesis, or whether this medication affects fertility in females.</p><h3>Pregnancy</h3><p class="First">There have been no reports that use of Nystatin Vaginal Inserts by pregnant women increases the risk of fetal abnormalities or affects later growth, development and functional maturation of the child. Nevertheless, because the possibility of harm cannot be ruled out, Nystatin Vaginal Inserts should be used during pregnancy only if the physician considers it essential to the welfare of the patient.</p><p>Animal reproduction studies have not been conducted with Nystatin Vaginal Inserts.</p><h3>Pediatric Use</h3><p class="First">Safety and effectiveness in pediatric patients have not been established.</p><h2>Adverse Reactions</h2><p class="First">Nystatin is virtually nontoxic and nonsensitizing and is well tolerated by all age groups, even on prolonged administration. Rarely, irritation or sensitization may occur (see PRECAUTIONS).</p><h2>Nystatin Vaginal Insert Dosage and Administration</h2><p class="First">The usual dosage is one insert (100,000 units nystatin) daily for two weeks.</p><p>The inserts should be deposited high in the vagina by means of the applicator. “Instructions for the Patient” are enclosed in each package.</p><h2>How is Nystatin Vaginal Insert Supplied</h2><p class="First">Nystatin Vaginal Inserts, USP:</p><p>Pale yellow mottled oval-shaped, flat face, beveled insert (Debossed ODYSSEY on one side and 705 on the other) are available in packages of 15 individually foil wrapped inserts, with applicator and “Instructions for the Patient”.</p><p>Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].</p><p>DURAMED PHARMACEUTICALS, INC.</p><p>Subsidiary of Barr Pharmaceuticals, Inc.               B08-0705<br/>
Pomona, New York  10970                                    R8-07 (V.2)<br/>
                                                                                15001177</p><h2>PRINCIPAL DISPLAY PANEL</h2><h3>Nystatin Vaginal Inserts, USP 100,000 Units 15s Package Text</h3><p class="First"><span class="Bold">NDC</span> 51285-<span class="Bold">534</span>-22</p><p><span class="Bold">Nystatin</span></p><p><span class="Bold">Vaginal</span></p><p><span class="Bold">Inserts, USP</span></p><p><span class="Bold">100,000 Units</span></p><p>Store at 20° to 25°C (68° to 77°F)</p><p>[See USP Controlled</p><p>Room Temperature].</p><p>REFRIGEATION NOT</p><p>REQUIRED.</p><p>Inactive ingredients:</p><p>Corn starch, ethylcellulose,</p><p>anhydrous lactose,</p><p>microcrystalline cellulose,</p><p>polyethylene glycol, stearic acid</p><p><span class="Bold">15 Vaginal Inserts</span></p><p><span class="Bold">with Applicator</span></p><p>DURAMED PHARMACEUTICALS, INC.</p><p>Subsidiary of Barr Pharmaceuticals, Inc.</p><p>Pomona, New York 10970</p><p><span class="Bold">Duramed Rx only</span></p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>Can triamcinolone acetonide B be used to treat severe diaper rash on a little girl?</li>
</ul><h2>More about nystatin</h2><ul class="more-resources-list more-resources-list-general">
<li>Side Effects</li>
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>64 Reviews</li>
<li>Drug class: mouth and throat products</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Nystatin &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(Advanced Reading)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li>Nystatin Oral Suspension &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(FDA)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
<li>Nystatin Tablets &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(FDA)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Gastrointestinal Candidiasis</li>
<li>Oral Thrush</li>
</ul><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>